GBM AGILE platform trial for newly diagnosed and recurrent GBM: Results of first experimental arm, regorafenib Meeting Abstract


Authors: Lassman, A.; Alexander, B.; Berry, D.; Buxton, M.; Cavenee, W.; Colman, H.; De Groot, J.; Ellingson, B.; Gordon, G.; Hyddmark, E. M. V.; Khasraw, M.; Lim, M.; Mellinghoff, I.; Mikkelsen, T.; Perry, J.; Powell, A.; Sulman, E.; Tanner, K.; Weller, M.; Yung, W. K. A.; Blondin, N.; Brenner, A.; Butt, O.; de la Fuente, M. I.; Drappatz, J.; Iwamoto, F.; Kim, L.; Lee, E.; Mantica, M.; Nabors, B.; Newton, H.; Schiff, D.; Walbert, T.; Weathers, S.; Cloughesy, T.; Wen, P. Y.
Abstract Title: GBM AGILE platform trial for newly diagnosed and recurrent GBM: Results of first experimental arm, regorafenib
Meeting Title: 19th Meeting of the European Association of Neuro-Oncology
Journal Title: Neuro-Oncology
Volume: 26
Issue: Suppl. 5
Meeting Dates: 2024 Oct 17-20
Meeting Location: Glasgow, United Kingdom
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2024-10-01
Start Page: v26
End Page: v27
Language: English
ACCESSION: WOS:001340502000078
DOI: 10.1093/neuonc/noae144.079
PROVIDER: wos
Notes: Meeting Abstract: OS09.7.A -- Abstract Citation ID: NOAE144.079 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors